Mouse peripheral blood mononuclear cells (PBMCs) are a practical starting material for immune profiling when a study needs to remain aligned with a defined mouse model. Because PBMCs represent circulating mononuclear immune populations, they can support phenotyping and ex vivo assay workflows without requiring isolation from a solid lymphoid organ.
For study planning, the important question is not simply whether to use mouse PBMCs, but which mouse background, cell quantity, quality information, and degree of immune-cell characterization are appropriate for the intended endpoint. The MileCell animal immune-cell portfolio lists mouse PBMCs from C57BL/6N, BALB/c, and CD-1 mice, with each listed product entry supplied at 10 million cells. The same portfolio also highlights high post-thaw viability, rigorous QC, available inventory, and customization by gender, species, pack size, and batch size.
| Selection principle: Choose the PBMC source to match the mouse model used in the surrounding study, then confirm cell number, post-thaw quality, and available characterization before finalizing the assay design. |
What Are Mouse PBMCs?
PBMCs are the mononuclear leukocyte fraction isolated from peripheral blood. They provide a mixed immune-cell context that can include T cells, B cells, NK cells, monocytes, and other mononuclear populations. For immune profiling, this mixed composition is useful when the experimental objective is to examine multiple circulating immune compartments within the same sample.
Mouse PBMCs are most useful when peripheral blood is the biologically appropriate compartment for the endpoint. If a project instead requires a lymphoid-organ-derived population, the same MileCell portfolio also lists mouse splenocytes and mouse splenic lymphocytes; those materials should be treated as distinct sample types rather than substitutes for PBMCs.
Why Mouse PBMC Selection Matters for Immune Profiling
1. Match the PBMC Source to the Mouse Model
The supplied portfolio lists C57BL/6N, BALB/c, and CD-1 mouse PBMCs. Selection should follow the strain used in the in vivo or surrounding preclinical program so the ex vivo cell source remains aligned with the study context.
2. Start with the Required Cell Number
The listed mouse PBMC product entries are supplied at 10 million cells. Assay format, number of markers, replicate structure, stimulation conditions, and expected cell loss during handling should be considered when determining whether that amount is appropriate for a study.
3. Review Post-Thaw Quality Without Assuming a Universal Threshold
High post-thaw viability is listed as a feature of the animal immune-cell portfolio. However, the supplied product information does not state one universal numerical post-thaw viability threshold for all mouse PBMC products. Product-specific quality information should therefore be reviewed rather than inferred.
4. Consider Immune-Cell Composition
A viable PBMC preparation is not automatically the right material for every immune-profiling endpoint. The relevant populations need to be present and interpretable within the selected sample. Flow-cytometric characterization, when available for the material under consideration, can help determine whether it fits the planned panel.
5. Plan for Repeated or Larger Studies
The portfolio lists customizable pack size and batch size. This can be useful when a project is expected to span multiple plates, time points, or experimental stages and consistent material is important across the study.
Mouse PBMC Options Listed in the MileCell Portfolio
The mouse PBMC portfolio currently lists three mouse backgrounds. The product information below is reproduced from the supplied animal primary-cell product material.
| Mouse PBMC Product | Cat. No. | Listed Size |
| C57BL/6N Mouse Peripheral Blood Mononuclear Cells (PBMCs) | mPB010C-CB | 10 million |
| BALB/c Mouse Peripheral Blood Mononuclear Cells (PBMCs) | mPB010C-BA | 10 million |
| CD-1 Mouse Peripheral Blood Mononuclear Cells (PBMCs) | mPB010C-CD | 10 million |
Table 1. Mouse PBMC products, catalog numbers, and listed cell quantity.
A Practical Workflow for Choosing Mouse PBMCs
A fit-for-purpose selection process can be kept simple if each decision is tied to the experimental question. Before choosing a mouse PBMC product, confirm the following:
· Which mouse strain is used in the corresponding in vivo or preclinical model?
· Is peripheral blood the correct biological compartment for the study endpoint?
· Which immune populations must be detected or quantified?
· How many total cells are required for the panel, controls, stimulation conditions, and replicates?
· What post-thaw QC and immune-cell characterization are available for the selected material?
· Will the study benefit from a coordinated batch plan for repeated experiments?
· Does the endpoint require mixed PBMCs, or would a defined immune subset be more appropriate?
| Study Question | PBMC Selection Consideration | Practical Implication |
| Which mouse model must the ex vivo assay represent? | Match the PBMC source to C57BL/6N, BALB/c, or CD-1 as appropriate. | Keeps the cell source aligned with the surrounding study model. |
| Which immune populations matter for the endpoint? | Review available characterization and design the flow-cytometry panel accordingly. | Reduces the risk of interpreting a readout from an unsuitable cell mixture. |
| How large is the study? | Confirm the 10-million-cell listed size and discuss pack / batch requirements if needed. | Supports replicate and multi-stage study planning. |
| Is a mixed PBMC population appropriate? | Use PBMCs for mixed mononuclear context or discuss custom subset isolation when a purified population is required. | Matches sample complexity to the biological question. |
How to Think About Flow-Cytometry Characterization
For mouse PBMC immune profiling, flow-cytometry data can be especially useful because the endpoint depends on the cellular composition actually present in the sample. The representative C57BL/6J mouse PBMC analysis below shows major leukocyte, monocyte, T-cell, B-cell, NK-cell, and CD4/CD8-defined T-cell populations.
Figure 1. Representative flow-cytometric characterization of C57BL/6J mouse PBMCs. The analysis shows CD45+ leukocytes (98.98%), Ly-6C+ monocytes (8.22%), CD3+ T cells (18.64%), CD19+ B cells (56.02%), CD49b+ NK cells (4.32%), and, within the CD3+ gate, CD4+CD8- helper T cells (47.85%) and CD4-CD8+ cytotoxic T cells (43.55%). The figure is presented on a white background with the original axes, gating, and reported values preserved.
| Important interpretation note: The flow-cytometry values above describe the representative C57BL/6J mouse PBMC sample shown and should not be generalized to other strains or preparations. The product portfolio section separately lists C57BL/6N, BALB/c, and CD-1 mouse PBMCs, so the figure is best used as an example of mouse PBMC immunophenotyping rather than as a specification for every listed product. |
When Mixed PBMCs Are Not the Right Starting Material
Some immune-profiling studies need the mixed-cell context of PBMCs; others require a defined population. The animal immune-cell portfolio states that custom cell-isolation services can be provided for immune subtypes including CD3/CD4/CD8, CD14, CD19, and CD56 according to project specifications. This option can be considered when a purified or enriched immune subset is more appropriate than a mixed PBMC preparation.
MileCell Mouse PBMCs for Immune Profiling Studies
For mouse-focused preclinical research, the portfolio provides C57BL/6N, BALB/c, and CD-1 PBMC options. The broader animal immune-cell offering emphasizes high post-thaw viability, rigorous QC for reliable cells and batch consistency, broad species coverage, available inventory, and customization by gender, species, pack size, and batch size.
The practical value of these options is flexibility in study planning: researchers can align the PBMC source with the mouse model, work from a defined listed cell quantity, review available quality and characterization information, and discuss batch or subset requirements when the study design calls for a more specific configuration.
| Next step: For a mouse PBMC immune-profiling study, select the matching strain first, confirm the total cell requirement, and review available QC and characterization before finalizing the panel and assay layout. |
Quick Reference: Evaluating Mouse PBMCs
| Evaluation Area | Key Question | Source-Supported Information |
| Strain selection | Does the PBMC source match the mouse model? | C57BL/6N, BALB/c, and CD-1 mouse PBMCs are listed. |
| Cell quantity | Is the listed cell number appropriate for the assay? | Each mouse PBMC product entry is listed at 10 million cells. |
| Post-thaw quality | What QC is available for the selected material? | High post-thaw viability is listed as a feature; no universal numerical threshold is stated for all mouse PBMCs. |
| Cell composition | Are the required immune populations represented? | A representative C57BL/6J mouse PBMC analysis provides CD45, Ly-6C, CD3, CD19, CD49b, and CD4/CD8 flow-cytometry data. |
| Study scale | Can supply be aligned with the project? | Pack size and batch size are listed as customizable. |
| Subset needs | Is mixed PBMC composition appropriate? | Custom isolation is available for CD3/CD4/CD8, CD14, CD19, CD56 and other specified immune subtypes. |
FAQ: Choosing Mouse PBMCs for Immune Profiling
Which mouse PBMC strains are listed by MileCell?
C57BL/6N, BALB/c, and CD-1 mouse PBMCs are listed in the supplied animal immune-cell portfolio.
What size are the listed mouse PBMC products?
Each listed mouse PBMC product entry is shown at 10 million cells.
Does the portfolio give one numerical post-thaw viability specification for all mouse PBMCs?
No. High post-thaw viability is listed as a product feature, but one universal numerical threshold is not stated for the full mouse PBMC portfolio.
Is mouse-specific flow-cytometry characterization provided?
Yes. The supplied mouse PBMC characterization data include a C57BL/6J example with CD45, Ly-6C, CD3, CD19, CD49b, and CD4/CD8 readouts. These results describe the sample shown and should not be used as universal reference ranges for other mouse PBMC products.
Can defined immune-cell subsets be isolated?
Custom isolation is listed for immune-cell subtypes such as CD3/CD4/CD8, CD14, CD19, and CD56 according to project specifications.
How should I choose among C57BL/6N, BALB/c, and CD-1 PBMCs?
Match the PBMC source to the mouse strain used in the surrounding study program, then confirm cell number, QC, and available characterization for the selected material.
Conclusion
Choosing mouse PBMCs for immune profiling is primarily a question of model alignment and study design. Start with the mouse strain used in the surrounding program, confirm that peripheral blood is the correct compartment, determine the cell number required for the assay, and review the post-thaw QC and characterization available for the selected material.
MileCell lists C57BL/6N, BALB/c, and CD-1 mouse PBMCs at 10 million cells per product entry, together with customizable pack and batch options and custom immune-subset isolation capabilities. Keeping these variables explicit at the planning stage helps build a more controlled and interpretable immune-profiling workflow without relying on unsupported assumptions about a strain or sample.
Looking for mouse PBMCs for immune profiling studies? Review the relevant mouse strain and available characterization information, or contact the MileCell team to discuss study scale and immune-subset requirements.
Contact: mailto:Info@milecell-bio.com | Website: www.milecell-bio.com
